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Abstract
© 2016 The Royal Society of Chemistry.Advanced glycation end products (AGEs) are associated
with various diseases, especially during aging and the development of diabetes and uremia. To
better understand these biological processes, investigation of the in vivo kinetics of AGEs, i.e.,
analysis of trafficking and clearance properties, was carried out by molecular imaging. Following
the preparation of Cy7.5-labeled AGE-albumin and intravenous injection in BALB/cA-nu/nu mice,
noninvasive fluorescence kinetics analysis was performed. In vivo imaging and fluorescence
microscopy analysis revealed that non-enzymatic AGEs were smoothly captured by scavenger
cells in the liver, i.e., Kupffer and other sinusoidal cells, but were unable to be properly cleared
from the body. Overall, these results highlight an important link between AGEs and various
disorders associated with them, which may serve as a platform for future research to better
understand the processes and mechanisms of these disorders.
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